EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Apyx Medical's Enterprise Value is $46.82 Mil.
Apyx Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-5.78 Mil. Therefore, Apyx Medical's EV-to-FCF for today is -8.10.
The historical rank and industry rank for Apyx Medical's EV-to-FCF or its related term are showing as below:
APYX'
s EV-to-FCF Range Over the Past 10 Years
Min: -269.37 Med: -14.93 Max: -2.15
Current: -8.1
During the past 13 years, the highest EV-to-FCF of Apyx Medical was -2.15. The lowest was -269.37. And the median was -14.93.
APYX's EV-to-FCF is ranked worse than 100% of 363
companies
in the Medical Devices & Instruments industry
Industry Median: 27.99
vs APYX: -8.10
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Apyx Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Apyx Medical's EV-to-FCF
For the Medical Devices subindustry, Apyx Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apyx Medical's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Apyx Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Apyx Medical's EV-to-FCF falls into.
Apyx Medical EV-to-FCF Calculation
Apyx Medical's EV-to-FCF for today is calculated as:
Apyx Medical's current Enterprise Value is $46.82 Mil.
Apyx Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apyx Medical (NAS:APYX) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Apyx Medical's PE Ratio for today is calculated as:
Apyx Medical's share price for today is $1.50.
Apyx Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Apyx Medical EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Apyx Medical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APYX has been successfully added to your 